• 2025
  Dugied G, Laurent EM, Attia M, Gimeno JP, Bachiri K, Samavarchi-Tehrani P, Donati F, Rahou Y, Munier S, Amara F, Dos Santos M, Soler N, Volant S, Pietrosemoli N, Gingras AC, Pavlopoulos GA, van der Werf S, Falter-Braun P, Aloy P, Jacob Y, Komarova A, Sofianatos Y, Coyaud E, Demeret C, Multimodal SARS-CoV-2 interactome sketches the virus-host spatial organization., Commun Biol 2025 Mar; 8(1): 501.
• 2024
  Dugied G, Douche T, Dos Santos M, Giai Gianetto Q Q, Cassonnet C, Vuillier F, Cassonnet P, Jacob Y, van der Werf S, Komarova A, Matondo M, Karim M, Demeret C, Profiling Cullin4-E3 ligases interactomes and their rewiring in influenza A virus infection., Mol Cell Proteomics 2024 Oct; (): 100856.
• 2024
  Aouadi W, Najburg V, Legendre R, Varet H, Kergoat L, Tangy F, Larrous F, Komarova AV, Bourhy H, Comparative analysis of rabies pathogenic and vaccine strains detection by RIG-I-like receptors., Microbes Infect 2024 ; 26(4): 105321.
• 2024
  Vera-Peralta H, Najburg V, Combredet C, Douché T, Gianetto QG, Matondo M, Tangy F, Mura M, Komarova AV, Applying Reverse Genetics to Study Measles Virus Interactions with the Host., Methods Mol Biol 2024 ; 2808(): 89-103.
• 2023
  Collados Rodríguez M, Maillard P, Journeaux A, Komarova AV, Najburg V, David RS, Helynck O, Guo M, Zhong J, Baize S, Tangy F, Jacob Y, Munier-Lehmann H, Meurs EF, Novel Antiviral Molecules against Ebola Virus Infection., Int J Mol Sci 2023 Sep; 24(19): .
• 2023
  Mateo M, Reynard S, Pietrosemoli N, Perthame E, Journeaux A, Noy K, Germain C, Carnec X, Picard C, Borges-Cardoso V, Hortion J, Lopez-Maestre H, Regnard P, Fellmann L, Vallve A, Barron S, Jourjon O, Lacroix O, Duthey A, Dirheimer M, Daniau M, Legras-Lachuer C, Carbonnelle C, Raoul H, Tangy F, Baize S, Rapid protection induced by a single-shot Lassa vaccine in male cynomolgus monkeys., Nat Commun 2023 Mar; 14(1): 1352.
• 2023
  Khalfi P, Suspène R, Raymond KA, Caval V, Caignard G, Berry N, Thiers V, Combredet C, Rufie C, Rigaud S, Ghozlane A, Volant S, Komarova AV, Tangy F, Vartanian JP, Antagonism of ALAS1 by the Measles Virus V protein contributes to degradation of the mitochondrial network and promotes interferon response., PLoS Pathog 2023 Feb; 19(2): e1011170.
• 2022
  Vabret N, Najburg V, Solovyov A, Gopal R, McClain C, Šulc P, Balan S, Rahou Y, Beauclair G, Chazal M, Varet H, Legendre R, Sismeiro O, Sanchez David RY, Chauveau L, Jouvenet N, Markowitz M, van der Werf S, Schwartz O, Tangy F, Bhardwaj N, Greenbaum BD, Komarova AV, Y RNAs are conserved endogenous RIG-I ligands across RNA virus infection and are targeted by HIV-1., iScience 2022 Jul; 25(7): 104599.
• 2022
  Di Gioacchino A, Legendre R, Rahou Y, Najburg V, Charneau P, Greenbaum BD, Tangy F, van der Werf S, Cocco S, Komarova AV, sgDI-tector: defective interfering viral genome bioinformatics for detection of coronavirus subgenomic RNAs., RNA 2022 Mar; 28(3): 277-289.
• 2021
  Frantz PN, Barinov A, Ruffié C, Combredet C, Najburg V, de Melo GD, Larrous F, Kergoat L, Teeravechyan S, Jongkaewwattana A, Billon-Denis E, Tournier JN, Prot M, Levillayer L, Conquet L, Montagutelli X, Tichit M, Hardy D, Fernandes P, Strick-Marchand H, Di Santo J, Simon-Lorière E, Bourhy H, Tangy F, A live measles-vectored COVID-19 vaccine induces strong immunity and protection from SARS-CoV-2 challenge in mice and hamsters., Nat Commun 2021 Nov; 12(1): 6277.
• 2021
  Nzounza P, Martin G, Dereuddre-Bosquet N, Najburg V, Gosse L, Ruffié C, Combredet C, Petitdemange C, Souquère S, Schlecht-Louf G, Moog C, Pierron G, Le Grand R, Heidmann T, Tangy F, A recombinant measles virus vaccine strongly reduces SHIV viremia and virus reservoir establishment in macaques., NPJ Vaccines 2021 Oct; 6(1): 123.
• 2021
  Mateo M, Reynard S, Journeaux A, Germain C, Hortion J, Carnec X, Picard C, Baillet N, Borges-Cardoso V, Merabet O, Vallve A, Barron S, Jourjon O, Lacroix O, Duthey A, Dirheimer M, Jouvion G, Moreau PH, Fellmann L, Carbonnelle C, Raoul H, Tangy F, Baize S, A single-shot Lassa vaccine induces long-term immunity and protects cynomolgus monkeys against heterologous strains., Sci Transl Med 2021 Jun; 13(597): .
• 2021
  Meignié A, Combredet C, Santolini M, Kovács IA, Douché T, Gianetto QG, Eun H, Matondo M, Jacob Y, Grailhe R, Tangy F, Komarova AV, Proteomic Analysis Uncovers Measles Virus Protein C Interaction With p65-iASPP Protein Complex., Mol Cell Proteomics 2021 ; 20(): 100049.
• 2020
  Delaunay T, Achard C, Boisgerault N, Grard M, Petithomme T, Chatelain C, Dutoit S, Blanquart C, Royer PJ, Minvielle S, Quetel L, Meiller C, Jean D, Fradin D, Bennouna J, Magnan A, Cellerin L, Tangy F, Grégoire M, Fonteneau JF, Frequent Homozygous Deletions of Type I Interferon Genes in Pleural Mesothelioma Confer Sensitivity to Oncolytic Measles Virus., J Thorac Oncol 2020 May; 15(5): 827-842.
• 2019
  Pagliuso A, Tham TN, Allemand E, Robertin S, Dupuy B, Bertrand Q, Bécavin C, Koutero M, Najburg V, Nahori MA, Tangy F, Stavru F, Bessonov S, Dessen A, Muchardt C, Lebreton A, Komarova AV, Cossart P, An RNA-Binding Protein Secreted by a Bacterial Pathogen Modulates RIG-I Signaling., Cell Host Microbe 2019 Dec; 26(6): 823-835.e11.
• 2019
  Sanchez David RY, Combredet C, Najburg V, Millot GA, Beauclair G, Schwikowski B, Léger T, Camadro JM, Jacob Y, Bellalou J, Jouvenet N, Tangy F, Komarova AV, LGP2 binds to PACT to regulate RIG-I- and MDA5-mediated antiviral responses., Sci Signal 2019 Oct; 12(601): .
• 2019
  Pliquet E, Ruffie C, Escande M, Thalmensi J, Najburg V, Combredet C, Bestetti T, Julithe M, Liard C, Huet T, Wain-Hobson S, Tangy F, Langlade-Demoyen P, Strong antigen-specific T-cell immunity induced by a recombinant human TERT measles virus vaccine and amplified by a DNA/viral vector prime boost in IFNAR/CD46 mice., Cancer Immunol Immunother 2019 Apr; 68(4): 533-544.
• 2019
  Gerke C, Frantz PN, Ramsauer K, Tangy F, Measles-vectored vaccine approaches against viral infections: a focus on Chikungunya., Expert Rev Vaccines 2019 Apr; 18(4): 393-403.
• 2019
  Mura M, Ruffié C, Combredet C, Aliprandini E, Formaglio P, Chitnis CE, Amino R, Tangy F, Recombinant measles vaccine expressing malaria antigens induces long-term memory and protection in mice., NPJ Vaccines 2019 ; 4(): 12.
• 2018
  Beauclair G, Mura M, Combredet C, Tangy F, Jouvenet N, Komarova AV, DI-tector: defective interfering viral genomes’ detector for next-generation sequencing data., RNA 2018 Oct; 24(10): 1285-1296.
• 2018
  Chazal M, Beauclair G, Gracias S, Najburg V, Simon-Lorière E, Tangy F, Komarova AV, Jouvenet N, RIG-I Recognizes the 5′ Region of Dengue and Zika Virus Genomes., Cell Rep. 2018 Jul 10;24(2):320-328.
• 2018
  Chazal M, Beauclair G, Gracias S, Najburg V, Simon-Lorière E, Tangy F, Komarova AV, Jouvenet N, RIG-I Recognizes the 5′ Region of Dengue and Zika Virus Genomes., Cell Rep 2018 Jul; 24(2): 320-328.
• 2017
  Mura M, Combredet C, Najburg V, Sanchez David RY, Tangy F, Komarova AV, Nonencapsidated 5′ Copy-Back Defective Interfering Genomes Produced by Recombinant Measles Viruses Are Recognized by RIG-I and LGP2 but Not MDA5., J Virol 2017 Oct; 91(20): .
• 2016
  Sanchez David RY, Combredet C, Sismeiro O, Dillies MA, Jagla B, Coppée JY, Mura M, Guerbois Galla M, Despres P, Tangy F, Komarova AV, Comparative analysis of viral RNA signatures on different RIG-I-like receptors., Elife 2016 Mar; 5(): e11275.
• 2015
  Ramsauer K, Schwameis M, Firbas C, Müllner M, Putnak RJ, Thomas SJ, Desprès P, Tauber E, Jilma B, Tangy F, Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial., Lancet Infect Dis 2015 May; 15(5): 519-27.
• 2014
  Lucas-Hourani M, Munier-Lehmann H, Helynck O, Komarova A, Desprès P, Tangy F, Vidalain PO, High-throughput screening for broad-spectrum chemical inhibitors of RNA viruses, J Vis Exp 2014;(87).
• 2013
  Brandler S, Ruffié C, Combredet C, Brault JB, Najburg V, Prevost MC, Habel A, Tauber E, Desprès P, Tangy F, A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus., Vaccine 2013 Aug; 31(36): 3718-25.
• 2013
  Komarova AV, Combredet C, Sismeiro O, Dillies MA, Jagla B, Sanchez David RY, Vabret N, Coppée JY, Vidalain PO, Tangy F, Identification of RNA partners of viral proteins in infected cells., RNA Biol 2013 Jun; 10(6): 944-56.
• 2011
  Komarova AV, Combredet C, Meyniel-Schicklin L, Chapelle M, Caignard G, Camadro JM, Lotteau V, Vidalain PO, Tangy F, Proteomic analysis of virus-host interactions in an infectious context using recombinant viruses., Mol Cell Proteomics 2011 Dec; 10(12): M110.007443.
• 2009
  Caignard G, Komarova AV, Bouraï M, Mourez T, Jacob Y, Jones LM, Rozenberg F, Vabret A, Freymuth F, Tangy F, Vidalain PO, Differential regulation of type I interferon and epidermal growth factor pathways by a human Respirovirus virulence factor, PLoS Pathog. 2009 Sep;5(9):e1000587.
• 2009
  Komarova AV, Haenni AL, Ramírez BC, Virus versus host cell translation love and hate stories, Adv. Virus Res. 2009;73:99-170.
• 2008
  Apcher S, Komarova A, Daskalogianni C, Yin Y, Malbert-Colas L, Fåhraeus R, mRNA translation regulation by the Gly-Ala repeat of Epstein-Barr virus nuclear antigen 1, J. Virol. 2009 Feb;83(3):1289-98.
• 2007
  Komarova AV, Real E, Borman AM, Brocard M, England P, Tordo N, Hershey JW, Kean KM, Jacob Y, Rabies virus matrix protein interplay with eIF3, new insights into rabies virus pathogenesis, Nucleic Acids Res. 2007;35(5):1522-32.
• 2006
  Brocard M, Paulous S, Komarova AV, Deveaux V, Kean KM, Evidence that PTB does not stimulate HCV IRES-driven translation, Virus Genes 2007 Aug;35(1):5-15.
• 2006
  Ben M'hadheb-Gharbi M, Gharbi J, Paulous S, Brocard M, Komaromva A, Aouni M, Kean KM, Effects of the Sabin-like mutations in domain V of the internal ribosome entry segment on translational efficiency of the Coxsackievirus B3, Mol. Genet. Genomics 2006 Oct;276(4):402-12.
• 2006
  Komarova AV, Brocard M, Kean KM, The case for mRNA 5′ and 3′ end cross talk during translation in a eukaryotic cell, Prog. Nucleic Acid Res. Mol. Biol. 2006;81:331-67.
• 2005
  Komarova AV, Chufistova LS, Aseev LV, Boni IV, [An Escherichia coli strain producing a leaderless mRNA from the chromosomal lac promoter], Bioorg. Khim. 2005 Sep-Oct;31(5):557-60.
• 2005
  Komarova AV, Tchufistova LS, Dreyfus M, Boni IV, AU-rich sequences within 5′ untranslated leaders enhance translation and stabilize mRNA in Escherichia coli, J. Bacteriol. 2005 Feb;187(4):1344-9.
• 2003
  Tchufistova LS, Komarova AV, Boni IV, A key role for the mRNA leader structure in translational control of ribosomal protein S1 synthesis in gamma-proteobacteria, Nucleic Acids Res. 2003 Dec;31(23):6996-7002.
• 2002
  Komarova AV, Tchufistova LS, Supina EV, Boni IV, Protein S1 counteracts the inhibitory effect of the extended Shine-Dalgarno sequence on translation, RNA 2002 Sep;8(9):1137-47.
• 2001
  Komarova AV, Chufistova LS, Supina EV, Boni IV, [Extensive complementarity of the Shine-Dalgarno region and 3′-terminal sequence of 16S ribosomal RNA is inefficient for translation in vivo], Bioorg. Khim. 2001 Jul-Aug;27(4):282-90.